This brand name is authorized in Nigeria.
The drug OCEXONE contains one active pharmaceutical ingredient (API):
1
|
UNII
023Z5BR09K - CEFTRIAXONE SODIUM
|
|
Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-7399 | Injection | Ocexone 1 g IV Injection INJ 1 g 1 x 1 vial | Powder for Injection/Infusion White to pale yellow crystalline powder Ocexone 1G IV Injection Ceftriaxone sodium Ceftriaxone Sodium A4-7399 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1x1 Prescription Only Medicine (POM) 24/09/2024 SWISS PHARMA NIGERIA LIMITED, 5,DOPEMU ROAD AGEGE 17745276 swipha@swiphanigeria.com Labesfal Laboratories Almiro S.A , LABESFAL LABORATOIRES ALMIRO, S.A, ZONA INDUSTRIAL DO LAGEDO, 3465-157, SANTIAGO DE BESTEIROS, PORTUGAL, Portugal | 30/01/2025 |
| A4-9169 | Injection | Ocexone 2 g Injection INJ 2 g 1 x 1 vial | Powder for Injection/Infusion A white or almost white powder Ocexone 2G Injection CEFTRIAXONE 2G Ceftriaxone Sodium 2G A4-9169 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1x1 Prescription Only Medicine (POM) 24/09/2024 SWISS PHARMA NIGERIA LIMITED, 5,DOPEMU ROAD AGEGE 17745276 swipha@swiphanigeria.com LABESFAL LABORATOIRES, LABESFAL LABORATOIRES ALMIRO, S.A, ZONA INDUSTRIAL DO LAGEDO, 3465-157, SANTIAGO DE BESTEIROS, PORTUGAL, Portugal | 30/01/2025 |
| C4-0003 | Injection | Ocexone 1 g IM Injection INJ 1 g 1 x 1 vial | Injection Ocexone 1G IM Injection CEFTRIAXONE 1G IM INJECTION Ceftriaxone Sodium 1G C4-0003 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1x1 Prescription Only Medicine (POM) 24/09/2024 SWISS PHARMA NIGERIA LIMITED, 5,DOPEMU ROAD AGEGE 17745276 swipha@swiphanigeria.com Labesfal Laboratories Almiro S.A , LABESFAL LABORATOIRES ALMIRO, S.A, ZONA INDUSTRIAL DO LAGEDO, 3465-157, SANTIAGO DE BESTEIROS, PORTUGAL, Portugal | 30/01/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD04 | Ceftriaxone | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-7399, A4-9169, C4-0003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.